1. 1. Handzel, Z. T., Barak, V., Altman, Y., Bibi, H., Lidgi, M., Iancovici-Kidon, M., Yassky, D., & Raz, M. (2007). Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. The Israel Medical Association journal : IMAJ, 9(6), 479–483.
2. 2. World Health Organization. (2019). Global tuberculosis report 2019. World Health Organization.
3. 3. Neelakantan, S., Nair, P. P., Emmanuel, R. V., & Agrawal, K. (2013). Diversities in presentations of extrapulmonary tuberculosis. BMJ case reports, 2013, bcr2013008597. https://doi.org/10.1136/bcr-2013-008597
4. 4. Winek, J., Demkow, U., Rowińska-Zakrzewska, E., Szołkowska, M., Filewska, M., Jagodziński, J., & Roszkowski-Sliz, K. (2009). Odpowiedź Th1-Th2 u chorych na gruźlice oraz osób zdrowych pozostajacych z nimi w styczności [Comparison of Th1 and Th2 response in the blood of tuberculous patients and healthy contacts]. Pneumonologia i alergologia polska, 77(5), 446–452.
5. 5. Hussain, R., Talat, N., Ansari, A., Shahid, F., Hasan, Z., & Dawood, G. (2011). Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study. Journal of clinical immunology, 31(5), 913–923. https://doi.org/10.1007/s10875-011-9566-y